K Barnette - VERU INC Chief Scientific Officer

All Insiders Germany . 
Stock . VERU INC DL 01 . Stakeholders . Insider . K Barnette
FMW Stock  EUR 0.68  0.01  1.45%   

Insider

K Barnette is Chief Scientific Officer of VERU INC DL 01 since 2018.
Age 52
Tenure 6 years
Phone305-509-6897
Webhttp://www.verupharma.com

VERU INC Management Efficiency

The company has return on total asset (ROA) of (0.331) % which means that it has lost $0.331 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7187) %, meaning that it generated substantial loss on money invested by shareholders. VERU INC's management efficiency ratios could be used to measure how well VERU INC manages its routine affairs as well as how well it operates its assets and liabilities.
VERU INC DL 01 has accumulated 15.25 M in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. VERU INC DL has a current ratio of 8.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist VERU INC until it has trouble settling it off, either with new capital or with free cash flow. So, VERU INC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VERU INC DL sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VERU to invest in growth at high rates of return. When we think about VERU INC's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

William GraceUnited Rentals
N/A
Jeffrey FentonUnited Rentals
66
Susan McCawAir Lease
57
Dale AsplundUnited Rentals
55
Joli GrossUnited Rentals
52
Jason ArnoldAir Lease
N/A
Michael DurandUnited Rentals
N/A
Matthew FlanneryUnited Rentals
58
Patrice VarrautBoiron SA
N/A
JeanChristophe BayssatBoiron SA
60
Fabrice ReyBoiron SA
N/A
Courtney McKeownAir Lease
N/A
Daniel HigginsUnited Rentals
N/A
II CPAAir Lease
43
Kenneth MettelUnited Rentals
N/A
Andrew LimogesUnited Rentals
40
Craig PintoffUnited Rentals
53
Eric LambertBoiron SA
N/A
Christine PlaceBoiron SA
N/A
Valrie LorentzPoinsotBoiron SA
54
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3 people. VERU INC DL 01 (FMW) is traded on Frankfurt Exchange in Germany and employs 233 people.

Management Performance

Return On Equity-0.72
Return On Asset-0.33

VERU INC DL Leadership Team

Elected by the shareholders, the VERU INC's board of directors comprises two types of representatives: VERU INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VERU. The board's role is to monitor VERU INC's management team and ensure that shareholders' interests are well served. VERU INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VERU INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jesus Socorro, Independent Director
Mario Eisenberger, Independent Director
K Barnette, Chief Scientific Officer
Grace Hyun, Independent Director
Charles Todd, Chief Executive Officer of The Female Health Company Division
Michael Rankowitz, Independent Director
Mitchell Steiner, Chairman of the Board, President, Chief Executive Officer
Michele Greco, Chief Financial Officer, Chief Administrative Officer
Harry Fisch, Vice Chairman of the Board, Chief Corporate Officer

VERU Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is VERU INC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.72
Return On Asset-0.33
Profit Margin(2.13) %
Operating Margin(2.11) %
Shares Outstanding80.62 M
Shares Owned By Insiders19.22 %
Shares Owned By Institutions49.02 %
Price To Earning381.84 X
Revenue39.35 M
Gross Profit30.59 M

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in VERU Stock

VERU INC financial ratios help investors to determine whether VERU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VERU with respect to the benefits of owning VERU INC security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY